Evaluation of Overall Health State, Treatment Burden, and Satisfaction with Insulin Efsitora Alfa (Efsitora) vs. Daily Comparator in Adults with Type 2 Diabetes in the QWINT Clinical Trial Program
Evaluation of Overall Health State, Treatment Burden, and Satisfaction with Insulin Efsitora Alfa (Efsitora) vs. Daily Comparator in Adults with Type 2 Diabetes in the QWINT Clinical Trial Program
Athena Philis-Tsimikis, Richard M. Bergenstal, Rebecca Threlkeld, Felicia Gelsey et al.
Journal
Diabetes Therapy
Topics
Diabetes Management and Education
article
Evaluation of Overall Health State, Treatment Burden, and Satisfaction with Insulin Efsitora Alfa (Efsitora) vs. Daily Comparator in Adults with Type 2 Diabetes in the QWINT Clinical Trial Program
Athena Philis-Tsimikis, Richard M. Bergenstal, Rebecca Threlkeld, Felicia Gelsey, Julio Rosenstock, Liza Ilag, Michael B. Davidson, Esther Levasseur, Harpreet S. Bajaj, Michael Case, Eden Miller
article en
Abstract
No abstract available for this paper.
Publication Tag
Diabetes TherapyVol. 17(3)
Institutions
Eli Lilly (United States) (US), Diabetes Australia (AU), Brampton Civic Hospital (CA), Dallas Diabetes Research Center (US), Scripps Whittier Diabetes Institute (US)